Thrombosis Current Events | Thrombosis News | 3
|
| Page
3 of
7 |
122 Results |
|
|
|
Sort By:
Page Views | Date |
Lords Call For Action On Air Travel and Health
There must be changes in the regulation and management of the air travel industry – accompanied by urgent research – if passenger and crew health is to be properly safeguarded. This call is made today in a Report by the House of Lords Science and Technology Committee – Air Travel and Health. The Report follows an Inquiry against... view more... (2000-11-22)
SCAI issues clinical alert on drug-eluting stents and late thrombosis
The Society for Cardiovascular Angiography and Interventions (SCAI) today released a clinical alert advising physicians on practical steps for reducing the risk of a rare but serious complication associated with the use of drug-eluting stents. view more (2007-01-11)
Patients who receive drug-eluting stents should continue antiplatelet medications
Patients who have had drug-eluting stents inserted to prop open blocked coronary arteries should continue to take medications to reduce the risk of blood clots for at least one year after the stent is inserted, a new scientific advisory recommends. view more (2007-01-17)
Research identifies in-flight emergencies
Fainting is the most common in-flight medical emergency. Research recently published in BioMed Central's open access journal Critical Care details the number, type and frequency of medical emergencies on board two airlines. view more (2009-01-26)
New guidelines issued for diagnosis and management of venous thromboembolism
The American Academy of Family Physicians (AAFP) and American College of Physicians (ACP) today released new clinical practice guidelines for the diagnosis and management of venous thromboembolism (VTE). view more (2007-01-30)
AJN study reveals compression stockings incorrectly used in 29 percent of patients
An original study, published in the September issue of the American Journal of Nursing (AJN), revealed that graduated compression stockings were used incorrectly in 29% of the patients and sized incorrectly in 26% of the patients. view more (2008-08-21)
ESC Congress 2003: Prothrombotic mutations are associated with increased cardiovascular events in postmenopausal women receiving hormone replacement therapy
IMPORTANT: This press release accompanies a poster or oral session given at the ESC Congress 2003. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology Recent studies have suggested that hormone replacement therapy may be associated with an increased... view more... (2003-09-01)
Study shows pine bark reduces jetlag
A new study published in the journal of Minerva Cardioangiologica reveals Pycnogenol, pine bark extract from the French maritime pine tree, reduces jetlag in passengers by nearly 50 percent. view more (2008-11-06)
Study Finds Half of Patients Undergoing Cerebrovascular Stent Placement Respond Poorly to the Antiplatelet Drug Clopidogrel (Plavix)
A study by researchers at Rush University Medical Center, published in the February issue of the American Journal of Neuroradiology, finds that half of patients undergoing cerebrovascular stent placement did not respond well to clopidogrel. Clopidogrel (Plavix) and aspirin are medications routinely prescribed for 1-3 months following... view more... (2008-02-06)
Thrombosis patients face greater risks than previously believed
Deep venous thrombosis (DVT), the formation of blood clots in the lower limbs, is the third-most common vascular disease in North America after heart attack and stroke, and is a frequent complication in hospitalized patients. view more (2008-12-03)
Curacyte awarded a EUR1.2M grant to fund development of Factor Xa inhibitors
Curacyte AG, a Munich-based drug development company, has announced that its wholly owned subsidiary, Curacyte Chemistry GmbH based in Jena, has been awarded a EUR1.2M R&D grant from the German State of Thuringia's Corporate Technology Development Program. The grant will fund the lead optimization and pre-clinical development of the Company's... view more... (2003-10-29)
New study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery
Transdermal delivery of estrogen therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to oral delivery, a new study suggests. view more (2009-03-27)
Understanding of cell protection mechanism points to therapies to prevent heart attacks and strokes
An understanding of how two genes cooperate to protect aortic muscle cells points to new therapies to treat arteriosclerosis, the major cause of heart attack and stroke, a study by Queen's University researchers concludes. view more (2006-07-20)
Jefferson scientists find high glucose before surgery raises risk of dangerous complications
Patients who have high blood sugar before undergoing surgery run an increased risk of developing blood clots, deep vein thrombosis and even pulmonary embolism after surgery. view more (2006-10-16)
Drug-eluting stents better than bare-metal stents for heart attack patients
Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare-metal stent; and that the... view more... (2009-09-28)
DES: New elements in the debate
Results announced at the 2006 ESC meeting in Barcelona questioned the long-term safety of drug eluting stents (DES) and sparked intense discussion. view more (2008-09-02)
Scientists Find New No-Needle Approach to Prevent Blood Clots
The dean of the University of Oklahoma College of Public Health and a team of scientists worldwide have found a better way to prevent deadly blood clots after joint replacement surgery - a major problem that results in thousands of unnecessary deaths each year. The research appears this week in the New England Journal of Medicine. view more (2009-08-12)
Call to reduce medical risks to refugees on repatriation
In a commentary article published this week in International Journal for Equity in Health, Siroos Mirzaei and co-authors call for medical professionals involved in the repatriation of refugees to "institute preventative measures to minimize the possible medical and psychological complications" that may result from their repatriation. view more (2003-10-31)
NEW SYNTHETIC ANTITHROMBOTIC DRUG COULD REDUCE DVT RISK AFTER HIP SURGERY (pp 1710, 1715, 1721)
Two studies in this week's issue of THE LANCET highlight how a new class of synthetic antithrombotic drug could be more effective than conventional therapy in reducing the risk of potentially fatal blood clots associated with hip-replacement surgery. Between 16 and 30% of patients who undergo Hip-replacement surgery have a risk... view more... (2002-05-15)
Elevated level of certain protein in urine linked to increased risk for blood clots
Preliminary research suggests that higher than normal levels of the protein albumin in urine is associated with an increased risk for blood clots in the deep veins of the legs or lungs (venous thromboembolism; VTE), according to a study in the May 6 issue of JAMA. view more (2009-05-06)
|
|
| Page
3 of
7 |
122 Results |
|
|
|
Sort By:
Page Views | Date |
|
